Chemical Formula: C20H17N3O4

Chemical Formula C20H17N3O4

Found 12 metabolite its formula value is C20H17N3O4

9-Aminocamptothecin

9-Aminocamptothecin (R,S)

C20H17N3O4 (363.1219002)


9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-08-08) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

9-Aminocamptothecin

8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H17N3O4 (363.1219002)


   

NCI60_004578

(19S)-8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione

C20H17N3O4 (363.1219002)


9-Aminocamptothecin is a pyranoindolizinoquinoline. Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others. Aminocamptothecin is a water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agents antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents 9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity[1]. 9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity[1].

   
   
   

benzyl N-[6-oxo-1-(2-oxoethyl)-2-phenylpyrimidin-5-yl]carbamate

benzyl N-[6-oxo-1-(2-oxoethyl)-2-phenylpyrimidin-5-yl]carbamate

C20H17N3O4 (363.1219002)


   

8-Amino-4-ethyl-4-hydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

8-Amino-4-ethyl-4-hydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

C20H17N3O4 (363.1219002)


   
   

9-amino-20-camptothecin

9-amino-20-camptothecin

C20H17N3O4 (363.1219002)


   

N-(6-acetyl-1,3-benzodioxol-5-yl)-5-methyl-2-phenyl-3-pyrazolecarboxamide

N-(6-acetyl-1,3-benzodioxol-5-yl)-5-methyl-2-phenyl-3-pyrazolecarboxamide

C20H17N3O4 (363.1219002)


   

1H-indazole-3-carboxylic acid 4-(1,3-dioxo-2-isoindolyl)butyl ester

1H-indazole-3-carboxylic acid 4-(1,3-dioxo-2-isoindolyl)butyl ester

C20H17N3O4 (363.1219002)


   

4-[3-(1,3-Dioxo-2-isoindolyl)propylamino]-2-methylisoindole-1,3-dione

4-[3-(1,3-Dioxo-2-isoindolyl)propylamino]-2-methylisoindole-1,3-dione

C20H17N3O4 (363.1219002)